<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
</head>
<body><p><strong>42. Ischaemic Heart Disease</strong></p><p>Ischaemic heart disease is a condition whereby there is reduced blood supply to the heart muscle. It comprises of stable angina pectoris and the acute coronary syndromes.</p><p>&nbsp;</p><p><strong><u>STABLE ANGINA PECTORIS</u></strong></p><p>Stable angina pectoris is pain or discomfort that occurs in the front of the chest, and may radiate to the neck, shoulders, jaw or arms. The chest pain is typically induced by exertion or emotional stress and relieved by rest or glyceryl trinitrate. Individuals who experience stable angina pectoris are at a high risk of developing acute coronary syndromes or a heart attack. Risk factors include diabetes mellitus, hypertension, cigarette smoking, plasma lipid abnormalities, obesity, family history of heart disease and persistently elevated markers of inflammation such as C-reactive protein.</p><p>Risk factors for this condition include obesity, diabetes mellitus, hypertension, smoking, hyperlipidaemia.</p><p><strong>CAUSES</strong></p><ul><li>Atherosclerosis with narrowing of the coronary blood vessels</li><li>Spasms of the coronary arteries</li></ul><p>&nbsp;</p><p><strong>SYMPTOMS</strong></p><ul><li>Central or precordial chest pain</li><li>May radiate into the left arm, neck or jaw</li><li>Relieved by rest</li><li>Relieved by glyceryl trinitrate</li></ul><p>&nbsp;</p><p><strong>SIGNS</strong></p><ul><li>No typical signs</li></ul><p>&nbsp;</p><p><strong>INVESTIGATIONS</strong></p><ul><li>12-lead ECG</li><li>Cardiac enzymes: creatinine kinase-MB (CK-MB) and troponins</li><li>Blood glucose</li><li>Blood lipid profile</li><li>FBC</li><li>Chest X-ray</li><li>Stress ECG</li><li>Echocardiography</li><li>Coronary angiography</li></ul><p>&nbsp;</p><p><strong>TREATMENT</strong></p><p>&nbsp;</p><p><strong>Treatment objectives</strong></p><ul><li>To minimise symptoms</li><li>To prevent progression to acute coronary syndromes</li><li>To identify and manage modifiable risk factors</li><li>To improve quality of life</li></ul><p>&nbsp;</p><p><strong>Non-pharmacological treatment</strong></p><ul><li>&nbsp; &nbsp; &nbsp; Educate and reassure patien</li><li>&nbsp; &nbsp; &nbsp; Healthy lifestyle modifications:</li><li>Diet</li><li>Exercise</li><li>Weight management</li><li>Reduction in alcohol consumption</li><li>Avoid or quit smoking</li></ul><p>&nbsp;</p><p><strong>Pharmacological treatment</strong></p><p><strong>A.&nbsp; Treating the acute chest pain</strong></p><p>Evidence Rating: [A]</p><p>• &nbsp;Glyceryl trinitrate, sublingual, 500 microgram stat. then as required</p><p><strong>And</strong></p><p>• &nbsp;Aspirin, oral, 300 mg stat. then 75 mg daily</p><p><strong>Or</strong></p><p>• &nbsp;Clopidogrel, oral, 300 mg stat. then 75 mg daily</p><p><strong>And</strong></p><p>• &nbsp;Atenolol, oral, 50-100 mg daily</p><p><strong>Or</strong></p><p>• &nbsp;Bisoprolol, oral, 5-10 mg daily</p><p><strong>Or</strong></p><p>• &nbsp;Metoprolol, oral, 50-100 mg 8-12 hourly</p><p>&nbsp;</p><p><strong>Note 7-1</strong></p><p><strong>Avoid betablockers in bronchial asthma, bradycardia, and hypotension; avoid atenolol in heart failure.</strong></p><p><strong>Or</strong></p><p>• &nbsp;Verapamil, oral, 80-120 mg 8 hourly</p><p>&nbsp;</p><p><strong>Note 7-2</strong></p><p><strong>Avoid in bradycardia, hypotension and in patients already on beta-blockers.</strong></p><p>&nbsp;</p><p>Optimise or initiate treatment for hypertension</p><ul><li> Optimise or initiate treatment for diabetes mellitus</li><li> Use statins to treat abnormal blood lipids to target levels</li></ul><p>&nbsp;</p><p><strong>B.&nbsp; If beta blockers or verapamil are contraindicated</strong></p><p>•&nbsp; Isosorbide dinitrate, oral, 10 mg 8-12 hourly</p><p>&nbsp;</p><p><strong>REFERRAL CRITERIA</strong></p><p>&nbsp;</p><p>Refer the following patients</p><p>•&nbsp; Those with no significant improvement in symptoms after the initial treatment above</p><p>•&nbsp; Those with worsening risk factors</p><p>&nbsp;</p>
    <p><strong> FLOWCHART</strong></p>
<div style="width: 95vw;">
<img src="https://osamfrimpong.github.io/stg_app_web/images/angina_pectoris.png" alt="Flowchart: Angina Pectoris" style="max-width: 100%;height: auto;margin: auto;">
</div>
<p><br /><strong>Fig 7-1: Flowchart: Angina Pectoris</strong></p>
    <p><strong><u>ACUTE CORONARY SYNDROME</u></strong></p><p>Acute Coronary Syndrome (ACS) is a term that describes symptoms resulting from severe acute myocardial ischaemia. The ischaemia may, or may not, lead to myocardial infarction (heart attack). ACS is classified as ST segment elevation on an electrocardiogram (ST-segment elevation myocardial infarction - STEMI) or a non-ST-segment elevation myocardial infarction (NSTEMI) and unstable angina (an ACS without elevation of cardiac enzymes). The risk factors for ACS are identical to those for, and include previous episodes of, stable angina pectoris.</p><p>Risk factors for this condition include obesity, diabetes mellitus, hypertension, smoking and hyperlipidaemia.</p><p><strong>CAUSES</strong></p><p>• &nbsp; &nbsp; Atherosclerosis or obstruction of the coronary blood vessels leading to reduction in blood supply to the heart muscle</p><p><strong>SYMPTOMS</strong></p><ul><li>Chest pain</li><li>Sudden onset</li><li>Varying degree but often severe and described as tightness, heaviness or constrictive in nature.</li><li>Persisting for more than 30 minutes</li><li>Not relieved by rest or glyceryl trinitrate</li><li>May radiate to the left arm, the neck or jaw</li><li>Nausea</li><li>Vomiting</li><li>Shortness of breath or fatigue (this may be the only presentation in diabetics and the elderly)</li><li>&nbsp;Loss of consciousness</li></ul><p>&nbsp;</p><p><strong>SIGNS</strong></p><ul><li>Restlessness and apprehension</li><li>Excessive sweating</li><li>Peripheral or central cyanosis</li><li>Pulse may be thready, fast, irregular, slow or normal</li><li>Blood pressure may be high, low or unrecordable (following extensive damage to heart muscle)</li><li>Bilateral crepitations in the chest (with left ventricular failure)</li><li>Presence of a third or fourth heart sound (suggests heart failure)</li><li>Confusion in the elderly</li></ul><p>&nbsp;</p><p><strong>INVESTIGATIONS</strong></p><ul><li>Standard 12 lead ECG</li><li>Cardiac enzymes: CK-MB, troponins T and I</li><li>Myoglobin</li><li>Serum lipid profile</li><li>Chest X-ray</li><li>Random blood glucose</li><li>FBC, ESR</li><li>Serum uric acid</li><li>Blood urea, electrolytes and creatinine</li><li>C-reactive protein</li><li>Echocardiography</li><li>Coronary angiography</li></ul><p>&nbsp;</p><p><strong>TREATMENT</strong></p><p><strong>Treatment objectives</strong></p><ul><li>To relieve distress and pain</li><li>To limit infarct size</li><li>To prevent and treat complications</li><li>To reverse cardiac remodelling</li><li>To prevent re-infarction</li><li>To identify and manage modifiable risk factors</li><li>To improve quality of life</li></ul><p>&nbsp;</p><p><strong>Non-pharmacological treatment</strong></p><ul><li>Reassure patient and encourage bed rest in the first 48 hours</li><li>Encourage cessation of smoking&nbsp;</li><li>Ensure weight reduction (in overweight and obese individuals) in the long term</li></ul><p>&nbsp;</p><p><strong>Pharmacological treatment</strong></p><p><strong>A.&nbsp; Initial treatment on admission</strong></p><p>Evidence Rating: [A]</p><p>• &nbsp;Oxygen, intranasal, by face mask or nasal cannula</p><p><strong>And</strong></p><p>• &nbsp;Aspirin, oral (chewable), 300 mg stat.</p><p><strong>And</strong></p><p>• &nbsp;Clopidogrel, oral, 300 mg stat.</p><p><strong>And</strong></p><p>• &nbsp;Glyceryl trinitrate, sublingual, 500 microgram stat.</p><p><strong>And</strong></p><p>• &nbsp;Morphine, IV, 5-10 mg stat.</p><p><strong>And</strong></p><p>• &nbsp;Metoclopramide, IV, 10 mg stat. (to prevent vomiting induced by</p><p>morphine)</p><p><strong>B.&nbsp; Maintenance treatment following immediately after initial treatment</strong></p><p>• &nbsp;Aspirin, oral, 75-300 mg daily indefinitely</p><p><strong>And</strong></p><p>• &nbsp;Clopidogrel, oral, 75 mg daily (patients who receive revascularisation therapy will require treatment for up to 12 months)</p><p><strong>C.&nbsp; Anticoagulation</strong></p><p>• Enoxaparin, SC, 1 mg/kg (100 units/kg) 12 hourly</p><p><strong>D.&nbsp; Prevention of cardiac arrhythmias and reduction of myocardial workload</strong></p><p>• &nbsp;Atenolol, oral, 25-100 mg daily (avoid only if beta-blockers are contraindicated)</p><p><strong>Or</strong></p><p>• &nbsp;Bisoprolol, oral, 5-20 mg daily</p><p><strong>Or</strong></p><p>• &nbsp;Metoprolol, oral, 50-100 mg 8-12 hourly</p><p><strong>And</strong></p><p>• &nbsp;Lisinopril, oral, 2.5-20 mg daily</p><p><strong>Or</strong></p><p>• &nbsp;Losartan, oral, 25-50 mg daily</p><p><strong>Or</strong></p><p>• &nbsp;Candesartan, oral, 4-16 mg daily</p><p><strong>And</strong></p><p>In patients with STEMI:</p><ul><li>Fibrinolytic agents may be given as reperfusion therapy in patients presenting with STEMI under specialist care.</li><li>Manage acute complications such as pulmonary oedema, cardiogenic shock and cardiac arrhythmias</li><li>Manage hyperglycaemia with insulin. Change diabetic patients previously on oral hypoglycaemic agents to insulin</li></ul><p>&nbsp;</p><p><strong>E.&nbsp; Long-term treatment (secondary prevention)</strong></p><p>• &nbsp;Aspirin, oral, 75-150 mg daily indefinitely</p><p><strong>And</strong></p><p>• &nbsp;Atenolol, oral, 25-100 mg daily (avoid only if beta-blockers are contraindicated)</p><p><strong>Or</strong></p><p>• &nbsp;Bisoprolol, oral, 5-20 mg daily</p><p><strong>Or</strong></p><p>• &nbsp;Metoprolol, oral, 50-100 mg 8-12 hourly</p><p><strong>F.&nbsp; To prevent cardiac remodelling and improve survival</strong></p><p>• &nbsp;Lisinopril, oral, 2.5-20 mg daily</p><p><strong>Or</strong></p><p>• &nbsp;Losartan, oral, 25-50 mg daily</p><p><strong>Or</strong></p><p>• &nbsp;Candesartan, oral, 4-16 mg daily</p><p>&nbsp;</p><p><strong>Note 7-3</strong></p><p><strong>Avoid ACE inhibitors and Angiotensin receptor blockers in patients with BP &lt; 100 mmHg</strong></p><p>&nbsp;</p><p><strong>G. To stabilise the clot and reduce blood cholesterol levels</strong></p><p>• &nbsp;Atorvastatin, oral, 20-40 mg daily</p><p><strong>Or</strong></p><p>• &nbsp;Rosuvastatin, oral, 10-20 mg daily</p><p><strong>Or</strong></p><p>• &nbsp;Simvastatin, oral, 40-80 mg daily. Statins are indicated irrespective of lipid levels</p><p><strong>H.&nbsp; To improve coronary dilatation and reduce myocardial workload</strong></p><p>• &nbsp;Isosorbide dinitrate, oral, 10 mg 8-12 hourly</p><p><strong>I. Control of hypertension and hyperglycaemia, if present</strong></p><p>(See appropriate sections)</p><p>&nbsp;</p><p><strong>REFERRAL CRITERIA</strong></p><p>All patients with suspected ACS require an urgent ECG. If ECG is not available or cannot be interpreted, refer immediately to a higher facility.</p><p>Patients with confirmed STEMI in any facility should be referred urgently to a Physician Specialist or Cardiologist for reperfusion therapy (after an initial oral dose of 300 mg of aspirin).</p><p>Other patients with N-STEMI and unstable angina should be referred to a physician specialist or cardiologist after the initial management above.</p>
</body>
</html>
